CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
immune response and demonstrate efficacy in patients with advanced triple-negative breast cancer.This study will ...
Phase 2
Columbus, Ohio, United States and 5 other locations
pelareorep and to see how well they work in treating patients with triple negative breast cancer that has spread ...
Phase 2
Columbus, Ohio, United States and 1 other location
This research study is studying a drug called Carboplatin with or without another study drug, Nivolumab as a possible treatment for triple-n ...
Phase 2
Columbus, Ohio, United States and 9 other locations
doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC). Usually, after neoadjuvant therapy and surgery for triple ne ...
Phase 3
Columbus, Ohio, United States and 216 other locations
or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...
Phase 3
Columbus, Ohio, United States and 144 other locations
Event Free Survival (EFS), in women with residual hormone receptor negative, HER2-negative ("triple negative") re ...
Phase 2
Columbus, Ohio, United States and 3 other locations
previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors do no...
Phase 3
Columbus, Ohio, United States of America and 508 other locations
with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors ...
Phase 3
Columbus, Ohio, United States and 508 other locations
with stage I to III TNBC with residual invasive disease in the breast and/or axillary lymph nodes at surgical resection following neoadjuvan...
Phase 3
Columbus, Ohio, United States and 359 other locations
III Study of Capivasertib + Paclitaxel versus Placebo + Paclitaxel as First line Treatment for Patients with Locally Advanced or Metastatic Triple...
Phase 3
Columbus, Ohio, United States and 260 other locations
Clinical trials
Research sites
Resources
Legal